A clinical retrospective on the most successful unapproved drug in American history.
Let's get one thing straight before we begin: a pharmacist invented Coca-Cola.
Not a chemist in a gleaming lab. Not a food scientist. Not a Silicon Valley founder disrupting the beverage space. A pharmacist. One who was, at the time of invention, personally managing a morphine addiction, experimenting with cocaine as a therapeutic substitute, and operating under zero regulatory oversight whatsoever.
His name was Dr. John Stith Pemberton. He was a licensed pharmacist and chemist in Atlanta, Georgia. He mixed up what would become the world’s most recognized beverage in a brass kettle in his backyard in 1886. And if he tried to bring it to market today, the FDA would not merely reject him — they would need a new category of rejection letter.
This is that story. Told with the appropriate level of clinical horror and professional respect.
Part One: Meet Dr. Pemberton, Confederate Veteran, Licensed Pharmacist, and Accidental Titan of Industry
John Stith Pemberton was born in 1831 in Knoxville, Georgia. He earned a medical degree from the Reform Medical College of Georgia at age 19, and went on to become one of the most successful pharmacists and chemists in Atlanta before the Civil War. During the Battle of Columbus in April 1865, he was slashed across the chest with a saber by Union cavalry. Like most wounded soldiers of that era with access to a pharmacy, he treated his pain with morphine. And like many of them, he became dependent on it.
He did what any pharmacist would do: he started experimenting. His first attempt at a morphine substitute was something called "Dr. Tuggle's Compound Syrup of Globe Flower" — derived from the buttonbush plant (Cephalanthus occidentalis), which is a toxic plant. This did not work. He moved on.
His next attempt was inspired by Vin Mariani, a Bordeaux wine mixed with coca leaf extract containing approximately 6mg of cocaine per serving — endorsed by Queen Victoria, President Grant, Thomas Edison, and Pope Leo XIII, who reportedly carried a flask of it and awarded the product a Vatican gold medal.
Part Two: Pemberton's French Wine Coca, or, The NDA That Never Was
By 1885, Pemberton had developed Pemberton's French Wine Coca — a tonic combining wine, coca leaf extract (cocaine), and kola nut (caffeine). He marketed it as a nerve tonic, mental stimulant, headache remedy, cure for indigestion, treatment for impotence, cure for morphine addiction, and cure for alcohol addiction.
There was no FDA. The Pure Food and Drug Act wouldn’t be passed until 1906. You could mix cocaine and alcohol, call it a nerve tonic and a morphine cure, sell it at a pharmacy counter, and the only oversight was whether people kept buying it. They did.
Then came Atlanta’s local prohibition law of 1886. Pemberton removed the alcohol, replaced the wine base with carbonated sugar syrup, kept the coca extract and the kola nut, and adjusted the flavor profile.
On May 8, 1886, he brought the new formula to Jacobs’ Pharmacy in Atlanta, where it was served at the soda fountain for five cents a glass. He called it Coca-Cola.
Part Three: What Happened Next
Pemberton was diagnosed with stomach cancer shortly after Coca-Cola launched. Sick and still managing his morphine addiction, he sold off pieces of the company. In 1888, he sold the remaining share to fellow Atlanta pharmacist Asa Griggs Candler for approximately $300. Pemberton died on August 16, 1888, at 57 years old, nearly broke and still addicted to morphine. Candler built Coca-Cola into a global empire. The Pemberton family received nothing further.
The pharmacist invented it. The businessman owned it. A story as old as pharmacy itself.
Part Four: The Clinical Review (Or, Let's Run This Through the FDA)
Let us conduct a brief, entirely hypothetical, deeply horrifying regulatory review of early Coca-Cola as if it were submitted to the FDA today.
Active Ingredients: Cocaine (from coca leaf extract) and caffeine (from kola nut). Both are Schedule II controlled substances under the Controlled Substances Act.
Proposed Indications: Nerve tonic, mental stimulant, headache remedy, indigestion treatment, impotence cure, and treatment for both morphine and alcohol dependence. To support these indications under 21 CFR Part 314, Pemberton would need Phase 1, 2, and 3 clinical trial data for each indication separately. Per FDA NDA guidance, Phase 3 trials typically enroll several hundred to 3,000 participants with randomized controlled trial design. Pemberton’s clinical trial data: a brass kettle and some personal experience. Number of Phase 3 trials submitted: zero.
Safety Profile: The cocaine content alone would require extensive toxicology covering acute toxicity, chronic toxicity, carcinogenicity, and reproductive safety studies. The addiction liability data — for a drug Pemberton was personally unable to quit — would constitute what the FDA might diplomatically call a signal.
Manufacturing Controls: Pemberton mixed his formula in a backyard brass kettle. No batch record. No stability testing. No certificate of analysis. No lot number.
Hypothetical FDA Complete Response Letter (excerpt): “Dear Mr. Pemberton: We are unable to approve this application. Deficiencies include: Schedule II controlled substance as primary active ingredient without approved indication; absence of any Phase 1, 2, or 3 clinical trial data; seven unevidenced therapeutic claims including cure of morphine dependence; no manufacturing controls or GMP documentation; no stability data; ‘nerve tonic’ is not a recognized medical condition. We also note that the sponsor appears to be personally dependent on the active ingredient.”
Part Five: When Did the Cocaine Actually Leave the Recipe?
Coca-Cola continued to contain the active alkaloids from coca leaf extract until approximately 1903, when public pressure pushed the company to use decocainized coca leaf instead. Today, the Stepan Company in Maywood, New Jersey holds the only DEA license in the United States to import and process coca leaves. They produce a decocainized coca leaf extract used as a flavoring agent for Coca-Cola. The cocaine is extracted and sold to Mallinckrodt, a pharmaceutical manufacturer, for use as a legitimate topical anesthetic.
Pharmacy is genuinely everywhere, and sometimes the supply chain reads like a pharmacy school exam question designed to confuse you.
Part Six: What This Actually Says About Pharmacy
John Pemberton was not a charlatan. He was a trained pharmacist operating in a world without the regulatory infrastructure that pharmacists now uphold every day. Every single layer of that system — the Pure Food and Drug Act, the Kefauver-Harris Amendment, the Controlled Substances Act, the FDA’s NDA process, GMP requirements — exists because of products like Pemberton’s.
The reason a pharmacist today catches dangerous interactions, verifies indications, and questions unevidenced claims is precisely because the 1886 version of the profession had no system to do any of that. The system was built by people who learned, sometimes catastrophically, what happens without it.
Pemberton invented Coca-Cola. Pharmacy built the world that makes sure nothing like it happens again without a 100,000-page NDA and a very long review period. That’s not a punchline. That’s the job.
Related Reading
0 comments